Optimizing Vaccine Responsiveness in HIV-1 and HCV Infections by Identifying Determinants of Responsiveness: A Pilot Study.
Phase of Trial: Phase I
Latest Information Update: 16 Dec 2014
At a glance
- Drugs Diphtheria-tetanus vaccine (Primary) ; Hepatitis A-hepatitis B vaccine (Primary)
- Indications Diphtheria; Hepatitis A; Hepatitis B; Tetanus
- Focus Pharmacodynamics; Registrational
- 07 Jun 2017 Biomarkers information updated
- 10 Apr 2012 Additional trial identifier (A5232) identified as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date changed from Sep 2009 to Jul 2009 as reported by ClinicalTrials.gov.